The lack of a comparator group in SEATTLE II precludes any conclusions regarding the relative safety of ultrasound-facilitated, catheter-directed, low-dose fibrinolysis compared with systemic fibrinolysis versus anticoagulation alone. The number of patients enrolled in the study was relatively small and may have limited the power of our multivariate analysis to identify significant predictors of bleeding.